Cargando…

Tolerability of NGX-4010, a capsaicin 8% patch, in conjunction with three topical anesthetic formulations for the treatment of neuropathic pain

BACKGROUND: The objective of this study was to assess the safety, tolerability, and preliminary efficacy of NGX-4010, a capsaicin 8% patch, following pretreatment with three different topical anesthetics in patients with peripheral neuropathic pain. METHODS: This open-label, multicenter study enroll...

Descripción completa

Detalles Bibliográficos
Autores principales:	Webster, Lynn R, Peppin, John F, Murphy, Frederick T, Tobias, Jeffrey K, Vanhove, Geertrui F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273402/ https://www.ncbi.nlm.nih.gov/pubmed/22328830 http://dx.doi.org/10.2147/JPR.S25272

Ejemplares similares

Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain
por: Peppin, John F, et al.
Publicado: (2011)

Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia
por: Webster, Lynn R, et al.
Publicado: (2010)

Tolerability of NGX-4010, a capsaicin 8% dermal patch, following pretreatment with lidocaine 2.5%/prilocaine 2.5% cream in patients with post-herpetic neuralgia
por: Webster, Lynn R, et al.
Publicado: (2011)

NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials
por: Brown, Stephen, et al.
Publicado: (2013)

Capsaicin 8% Patch and Chronic Postsurgical Neuropathic Pain
por: Giaccari, Luca Gregorio, et al.
Publicado: (2021)

Topical Capsaicin for the Treatment of Sensory Neuropathic Cough
por: Hoesli, Rebecca C., et al.
Publicado: (2021)

Treatment of Neuropathic Pain with the Capsaicin 8% Patch: Is Pretreatment with Lidocaine Necessary?
por: Kern, Kai-Uwe, et al.
Publicado: (2014)

The Capsaicin 8% Patch for Neuropathic Pain in Clinical Practice: A Retrospective Analysis
por: Wagner, Till, et al.
Publicado: (2013)

Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain
por: Haanpää, M., et al.
Publicado: (2015)

Check Point NGX R65 Security Administration
por: Bonnell, Ralph
Publicado: (2008)

Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch
por: Anand, P., et al.
Publicado: (2011)

Compact quadrupole (MPS 4010-000-0)
por: Szeless, B
Publicado: (1973)

Peripheral Neuropathic Pain Following Breast Cancer: Effectiveness and Tolerability of High-Concentration Capsaicin Patch
por: Dupoiron, Denis, et al.
Publicado: (2022)

Superiority of capsaicin 8% patch versus oral pregabalin on dynamic mechanical allodynia in patients with peripheral neuropathic pain
por: Cruccu, G., et al.
Publicado: (2017)

Cost-Effectiveness of Capsaicin 8% Patch Compared with Pregabalin for the Treatment of Patients with Peripheral Neuropathic Pain in Scotland
por: Mankowski, Colette, et al.
Publicado: (2016)

Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study
por: Mankowski, Colette, et al.
Publicado: (2017)

Evaluation of In Vitro Capsaicin Release and Antimicrobial Properties of Topical Pharmaceutical Formulation
por: Goci, Enkelejda, et al.
Publicado: (2021)

Configuring Check Point NGX VPN-1/FireWall-1
por: Stephens, Robert, et al.
Publicado: (2005)

Profile of the capsaicin 8% patch for the management of neuropathic pain associated with postherpetic neuralgia: safety, efficacy, and patient acceptability
por: Laklouk, Muhammad, et al.
Publicado: (2016)

Trigeminal postherpetic neuralgia responsive to treatment with capsaicin 8 % topical patch: a case report
por: Sayanlar, Jennifer, et al.
Publicado: (2012)

Treatment of peripheral neuropathic pain by topical capsaicin: Impact of pre-existing pain in the QUEPP-study
por: Maihöfner, CG, et al.
Publicado: (2014)

Expert Opinion: Exploring the Effectiveness and Tolerability of Capsaicin 179 mg Cutaneous Patch and Pregabalin in the Treatment of Peripheral Neuropathic Pain
por: Huygen, Frank, et al.
Publicado: (2020)

Pharmacodynamic analysis of the analgesic effect of capsaicin 8% patch (Qutenza™) in diabetic neuropathic pain patients: detection of distinct response groups
por: Martini, Christian, et al.
Publicado: (2012)

Considerable Variability in the Efficacy of 8% Capsaicin Topical Patches in the Treatment of Chronic Pruritus in 3 Patients with Notalgia Paresthetica
por: Andersen, Hjalte H., et al.
Publicado: (2016)

Quantitative Thermal Testing Profiles as a Predictor of Treatment Response to Topical Capsaicin in Patients with Localized Neuropathic Pain
por: Serrano, A., et al.
Publicado: (2017)

TG4010: A therapeutic vaccine against MUC1 expressing tumors
por: Limacher, Jean-Marc, et al.
Publicado: (2012)

Vaccination Granuloma Itch Treated with Capsaicin 8% Patches
por: HOFFMANN, Stine, et al.
Publicado: (2020)

NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer
por: Liu, Minji, et al.
Publicado: (2010)

Intradermal Tests for Diagnosis of Drug Allergy are not Affected by a Topical Anesthetic Patch
por: Couto, Mariana, et al.
Publicado: (2014)

Pain‐relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice
por: Hansson, P., et al.
Publicado: (2018)

Capsaicin 8% patch as therapy for neuropathic chronic postsurgical pain after melanoma excision surgery: A single center case series
por: Laude-Pagniez, Eulalie, et al.
Publicado: (2022)

Multicenter assessment of quantitative sensory testing (QST) for the detection of neuropathic-like pain responses using the topical capsaicin model
por: Ferland, Catherine E., et al.
Publicado: (2018)

Development of Capsaicin-Containing Analgesic Silicone-Based Transdermal Patches
por: László, Szabolcs, et al.
Publicado: (2022)

Tolerability of the capsaicin 8% patch following pretreatment with lidocaine or tramadol in patients with peripheral neuropathic pain: A multicentre, randomized, assessor-blinded study
por: Jensen, TS, et al.
Publicado: (2014)

Topical Capsaicin for Treating Cannabinoid Hyperemesis Syndrome
por: Aziz, Ansar, et al.
Publicado: (2020)

Interest of a standardized hypnotic message for the reduction of pain and anxiety in cancer patients treated by capsaicin patch for neuropathic pain: a randomized controlled trial
por: Etienne, Rémi, et al.
Publicado: (2021)

8% Capsaicin Patch as Analgesia for Severe Treprostinil Infusion Site Pain
por: Light, Allison, et al.
Publicado: (2017)

Are We Ready to Recommend Capsaicin for Disorders Other Than Neuropathic Pain?
por: Silva, Janayne L., et al.
Publicado: (2023)

Progressive Response to Repeat Application of Capsaicin 179 mg (8% w/w) Cutaneous Patch in Peripheral Neuropathic Pain: Comprehensive New Analysis and Clinical Implications
por: Freynhagen, Rainer, et al.
Publicado: (2021)

Personalized anesthetic patches for dental applications
por: Ou, Yi-Hsuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oaa8oftm3b0ia88iqeeadqi49g